Sarepta Therapeutics, Inc. SRPT Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s common stock?
- Sarepta Therapeutics, Inc. (SRPT) reported common stock of $11K in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s common stock changed year-over-year?
- Sarepta Therapeutics, Inc.'s common stock increased by 10.0% year-over-year, from $10K to $11K.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s common stock has grown at a 6.6% compound annual growth rate (CAGR), from $8K to $11K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).